Share this article

In the Asia-Pacific medical devices industry, there were 22 M&A deals announced in Q3 2023, worth a total value of $223.6m, according to GlobalData’s Deals Database. The $64.9m majority acquisition of Casstar Medical Technology Wuxi by Genertec Universal Medical Technology Services (Tianjin) was the industry’s largest disclosed deal. GlobalData’s Medical Devices Industry Mergers and Acquisitions Deals by Top Themes in Q3 2023 report helps understand the pivotal themes steering M&A activity in the industry. Buy the report here.

Smarter leaders trust GlobalData

In value terms, M&A activity in Asia-Pacific decreased by 77% in Q3 2023 compared with the previous quarter’s total of $973.9m and rose by 594% as compared to Q3 2022. Related deal volume decreased by 27% in Q3 2023 versus the previous quarter and was 69% higher than in Q3 2022.

The top-ranked financial advisors supporting these M&A deals in Asia-Pacific in Q3 2023 were Wodehouse Capital Advisors Private; IMAP; JPMorgan Chase & Co with 2, 1, 1 deals respectively.

The top-ranked legal advisors supporting these M&A deals in Asia-Pacific Q3 2023 were Khaitan & Co; Ropes & Gray; Bae, Kim & Lee with 3, 2, 1 deals respectively.

For further understanding of GlobalData's Medical Devices Industry Mergers And Acquisitions Deals By Top Themes In Q3 2023 – Thematic Intelligence, buy the report here.

This content was updated on 20 October 2023

Premium Insights


The gold standard of business intelligence.

Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.


GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.

GlobalData’s Deals Database tracks global deal activity, including mergers, acquisitions, capital raising, strategic alliances, and licensing agreements. Proprietary analysis is used to group deals into key thematic areas and granular sectors across the world’s largest industries.

This analysis considers only announced and completed deals from the GlobalData financial deals database and excludes all terminated and rumoured deals. Deal type includes Acquisition, Asset transactions and Mergers.